Lavaca Capital’s CVS Health CVS Stock Holding History

Lavaca Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,554	Closed	-$885K	–	146
2022 Q2	$885K	Buy	9,554 +4	+0%	+$390	0.13%	88
2022 Q1	$967K	Buy	+9,550	New	+$1M	0.1%	113

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lavaca Capital's CVS Position: Q3 2022 in Review

Lavaca Capital sold out of CVS Health (CVS) in Q3 2022, closing a stake of 9,554 shares — an estimated $885K sold.

Lavaca Capital first reported a position in CVS in Q1 2022 and held it in 2 quarters. The position peaked at $967K in Q1 2022. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

Lavaca Capital reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
Lavaca Capital sold 9,554 CVS Health shares in Q3 2022, an estimated $885K.
Lavaca Capital first reported a position in CVS Health in Q1 2022 and held it in 2 quarters.
Lavaca Capital's CVS Health position peaked at $967K in Q1 2022.
2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Lavaca Capital's 13F filing for Q3 2022, filed 14 Nov 2022.